De novo Design of SARS-CoV-2 Main Protease Inhibitors

被引：8

作者：

Fischer, Christian ^{[1
]}

Veprek, Nynke A. ^{[1
,2
]}

Peitsinis, Zisis ^{[1
]}

Ruhmann, Klaus-Peter ^{[1
]}

Yang, Chao ^{[1
]}

Spradlin, Jessica N. ^{[3
]}

Dovala, Dustin ^{[4
]}

Nomura, Daniel K. ^{[3
]}

Zhang, Yingkai ^{[1
]}

Trauner, Dirk ^{[1
]}

机构：

[1] NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA

[2] Ludwig Maximilians Univ Munchen, Dept Chem, Butenandtstr 5-13, D-81377 Munich, Germany

[3] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA

[4] Novartis Inst BioMed Res, Emeryville, CA 94608 USA

来源：

SYNLETT | 2022年 / 33卷 / 05期

基金：

美国国家卫生研究院; 瑞士国家科学基金会;

关键词：

viral main protease; small-molecule inhibitor; SARS-CoV-2; coronavirus; molecular modeling;

D O I：

10.1055/a-1582-0243

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, M-Pro , is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar noncovalent inhibitors of the viral main protease.

引用

页码：458 / 463

页数：6

共 50 条

[1] De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes
Zhu, Yan
Meng, Jiaolong
Feng, Bo
Zhao, Yao
Zang, Yi
Lu, Lingling
Su, Mingbo
Yang, Qi
Zhang, Qi
Feng, Lu
Zhao, Jinyi
Shao, Maolin
Ma, Yuanyuan
Yang, Xiuna
Yang, Haitao
Li, Jia
Jiang, Xuefeng
Rao, Zihe
STRUCTURE, 2024, 32 (09)
[2] Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
Morris, Aaron
McCorkindale, William
Drayman, Nir
Chodera, John D.
Tay, Savas
London, Nir
Lee, Alpha A.
CHEMICAL COMMUNICATIONS, 2021, 57 (48) : 5909 - 5912
[3] DE NOVO DESIGN OF POTENTIAL SARS-CoV-2 MAIN PROTEASE INHIBITORS USING ARTIFICIAL INTELLIGENCE AND MOLECULAR MODELING TECHNOLOGIES
Andrianov, Alexander M.
Furs, Konstantin, V
Shuldau, Mikita A.
Tuzikov, Alexander, V
DOKLADY NATSIONALNOI AKADEMII NAUK BELARUSI, 2023, 67 (03): : 197 - 206
[4] Allosteric inhibitors of the main protease of SARS-CoV-2
Samrat, Subodh Kumar
Xu, Jimin
Xie, Xuping
Gianti, Eleonora
Chen, Haiying
Zou, Jing
Pattis, Jason G.
Elokely, Khaled
Lee, Hyun
Li, Zhong
Klein, Michael L.
Shi, Pei-Yong
Zhou, Jia
Li, Hongmin
ANTIVIRAL RESEARCH, 2022, 205
[5] Developing inhibitors of the SARS-CoV-2 main protease
Seitz, Christian
Markota, Vedran
Sztain-Pedone, Terra
Esler, Morgan
Moghadasi, Arad
Kennelly, Samantha
Demir, Ozlem
Aihara, Hideki
Harki, Daniel A.
Harris, Reuben
McCammon, J. Andrew
Amaro, Rommie E.
BIOPHYSICAL JOURNAL, 2022, 121 (03) : 192A - 192A
[6] Potential SARS-CoV-2 main protease inhibitors
Banerjee, Riddhidev
Perera, Lalith
Tillekeratne, L. M. Viranga
DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
[7] On the origins of SARS-CoV-2 main protease inhibitors
Janin, Yves L.
RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
[8] Perspectives on SARS-CoV-2 Main Protease Inhibitors
Gao, Kaifu
Wang, Rui
Chen, Jiahui
Tepe, Jetze J.
Huang, Faqing
Wei, Guo-Wei
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16922 - 16955
[9] De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Cao, Longxing
Goreshnik, Inna
Coventry, Brian
Case, James Brett
Miller, Lauren
Kozodoy, Lisa
Chen, Rita E.
Carter, Lauren
Walls, Alexandra C.
Park, Young-Jun
Strauch, Eva-Maria
Stewart, Lance
Diamond, Michael S.
Veesler, David
Baker, David
SCIENCE, 2020, 370 (6515) : 426 - +
[10] Discovery of novel inhibitors of SARS-CoV-2 main protease
Zheng, Lei
Chen, Yanmei
Bao, Jingxiao
He, Liping
Dong, Suzhen
Qi, Yifei
Zhang, John Z. H.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12526 - 12534

← 1 2 3 4 5 →